鼻结膜炎和鼻窦炎的非药物治疗。

Journal of allergy Pub Date : 2014-01-01 Epub Date: 2014-12-21 DOI:10.1155/2014/416236
Ralph Mösges, Carlos E Baena-Cagnani, Desiderio Passali
{"title":"鼻结膜炎和鼻窦炎的非药物治疗。","authors":"Ralph Mösges, Carlos E Baena-Cagnani, Desiderio Passali","doi":"10.1155/2014/416236","DOIUrl":null,"url":null,"abstract":"Infectious and allergic diseases of the upper airways are among the most common illnesses of all age groups. Numerous guidelines have been issued for the evidence-based treatment of these diseases. Therapy involves local or systemic application of well-characterized pharmacologically active medications such as glucocorticosteroids, antihistamines, leukotriene-receptor antagonists, alpha-adrenergic receptor agonists, mast-cell stabilizers, and a monoclonal antibody targeting specific immunoglobulin E. In spite of the fact that the various therapeutic options have proven their efficacy and effectiveness in a myriad of well-designed clinical trials, many patients express their discontent with current therapies. In several surveys a majority of patients stated that they would prefer nonpharmacological “nonchemical” treatment over what is currently prescribed or recommended by their physicians. This desire stands in clear contrast to a systematic review conducted some years ago proving that there was practically no evidence at that time for the efficacy of alternative forms of treatment of allergic diseases of the upper airways. \n \nEver since, several meta-analyses, systematic reviews, and well-designed clinical trials have been published, bearing witness to the scientific basis of some nonpharmacologic options like nasal irrigation in the treatment of different pathologies of the upper airways, namely, for rhinosinusitis and for allergic rhinoconjunctivitis. \n \nIn this special issue, we want to highlight some new approaches that until lately have found less public attention in this domain. \n \nIn their article on the clinical efficacy of a spray containing hyaluronic acid and dexpanthenol after surgery in the nasal cavity, I. Gouteva et al. demonstrate beneficial effects on wound healing for two substances that have a long history of local application in the nose but formerly were used separately. \n \nThe so-called “extremolyte” ectoine is a substance, which was introduced a few years ago as a “natural” treatment of allergic and inflammatory pathologies of the skin and the mucosal tissues. Five articles in this issue illuminate the mechanism of action and the potential benefits of a nasal spray containing ectoine in diseases of various aetiologies like rhinitis sicca or allergic rhinitis. \n \nA form of local treatment of the nasal mucosa that is proximate to ectoine is the nasal spray containing liposomes. Its use in allergic rhinitis has been well established. A. Eitenmuller and coauthors present in their article for the first time data on ectoine in chronic rhinosinusitis. \n \nFor patients who are sceptical about using any sort of active ingredients in their nasal spray, the application of mere water in the form of thermal water inhalations could be an alternative. S. Keller et al. have conducted a meta-analysis which demonstrates some benefits of this least-invasive local therapy. \n \nThere has been much controversy over the last decade on the meaningfulness of probiotics in preventing allergies. New forms now come as treatment of chronic diseases of the upper airways. M. F. Kramer and his coauthor M. D. Heath present the latest state of knowledge of this nutritional therapeutic approach. \n \nAnother much debated therapy in the field of allergic diseases is acupuncture. Most investigations have previously focussed on pollen-allergic patients. It is the merit of Hauswald and coauthors to have conducted a randomized controlled clinical trial using acupuncture as an alternative to treatment with the state-of-the-art antihistamine loratadine in house dust allergic patients. \n \nIt has been the intention of the editors of this special issue to round up our knowledge on alternative therapies for upper airways diseases beyond the fields of herbal medicine and homeopathy. The number of articles that have been submitted but more so their quality was a positive surprise. \n \nWe are very grateful to the publishers who have had the courage of disseminating unusual ideas. Ghada Ali and Marie-Josefine Joisten were the driving spirits behind the scenes and without their continuous commitment this special issue would not have seen the light of the day. We are deeply obliged and thankful for their endeavours. \n \n \nRalph Mosges \n \nCarlos E. Baena-Cagnani \n \nDesiderio Passali","PeriodicalId":88910,"journal":{"name":"Journal of allergy","volume":"2014 ","pages":"416236"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/416236","citationCount":"2","resultStr":"{\"title\":\"Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis.\",\"authors\":\"Ralph Mösges, Carlos E Baena-Cagnani, Desiderio Passali\",\"doi\":\"10.1155/2014/416236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Infectious and allergic diseases of the upper airways are among the most common illnesses of all age groups. Numerous guidelines have been issued for the evidence-based treatment of these diseases. Therapy involves local or systemic application of well-characterized pharmacologically active medications such as glucocorticosteroids, antihistamines, leukotriene-receptor antagonists, alpha-adrenergic receptor agonists, mast-cell stabilizers, and a monoclonal antibody targeting specific immunoglobulin E. In spite of the fact that the various therapeutic options have proven their efficacy and effectiveness in a myriad of well-designed clinical trials, many patients express their discontent with current therapies. In several surveys a majority of patients stated that they would prefer nonpharmacological “nonchemical” treatment over what is currently prescribed or recommended by their physicians. This desire stands in clear contrast to a systematic review conducted some years ago proving that there was practically no evidence at that time for the efficacy of alternative forms of treatment of allergic diseases of the upper airways. \\n \\nEver since, several meta-analyses, systematic reviews, and well-designed clinical trials have been published, bearing witness to the scientific basis of some nonpharmacologic options like nasal irrigation in the treatment of different pathologies of the upper airways, namely, for rhinosinusitis and for allergic rhinoconjunctivitis. \\n \\nIn this special issue, we want to highlight some new approaches that until lately have found less public attention in this domain. \\n \\nIn their article on the clinical efficacy of a spray containing hyaluronic acid and dexpanthenol after surgery in the nasal cavity, I. Gouteva et al. demonstrate beneficial effects on wound healing for two substances that have a long history of local application in the nose but formerly were used separately. \\n \\nThe so-called “extremolyte” ectoine is a substance, which was introduced a few years ago as a “natural” treatment of allergic and inflammatory pathologies of the skin and the mucosal tissues. Five articles in this issue illuminate the mechanism of action and the potential benefits of a nasal spray containing ectoine in diseases of various aetiologies like rhinitis sicca or allergic rhinitis. \\n \\nA form of local treatment of the nasal mucosa that is proximate to ectoine is the nasal spray containing liposomes. Its use in allergic rhinitis has been well established. A. Eitenmuller and coauthors present in their article for the first time data on ectoine in chronic rhinosinusitis. \\n \\nFor patients who are sceptical about using any sort of active ingredients in their nasal spray, the application of mere water in the form of thermal water inhalations could be an alternative. S. Keller et al. have conducted a meta-analysis which demonstrates some benefits of this least-invasive local therapy. \\n \\nThere has been much controversy over the last decade on the meaningfulness of probiotics in preventing allergies. New forms now come as treatment of chronic diseases of the upper airways. M. F. Kramer and his coauthor M. D. Heath present the latest state of knowledge of this nutritional therapeutic approach. \\n \\nAnother much debated therapy in the field of allergic diseases is acupuncture. Most investigations have previously focussed on pollen-allergic patients. It is the merit of Hauswald and coauthors to have conducted a randomized controlled clinical trial using acupuncture as an alternative to treatment with the state-of-the-art antihistamine loratadine in house dust allergic patients. \\n \\nIt has been the intention of the editors of this special issue to round up our knowledge on alternative therapies for upper airways diseases beyond the fields of herbal medicine and homeopathy. The number of articles that have been submitted but more so their quality was a positive surprise. \\n \\nWe are very grateful to the publishers who have had the courage of disseminating unusual ideas. Ghada Ali and Marie-Josefine Joisten were the driving spirits behind the scenes and without their continuous commitment this special issue would not have seen the light of the day. We are deeply obliged and thankful for their endeavours. \\n \\n \\nRalph Mosges \\n \\nCarlos E. Baena-Cagnani \\n \\nDesiderio Passali\",\"PeriodicalId\":88910,\"journal\":{\"name\":\"Journal of allergy\",\"volume\":\"2014 \",\"pages\":\"416236\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2014/416236\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2014/416236\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/12/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/416236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/12/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis.
Infectious and allergic diseases of the upper airways are among the most common illnesses of all age groups. Numerous guidelines have been issued for the evidence-based treatment of these diseases. Therapy involves local or systemic application of well-characterized pharmacologically active medications such as glucocorticosteroids, antihistamines, leukotriene-receptor antagonists, alpha-adrenergic receptor agonists, mast-cell stabilizers, and a monoclonal antibody targeting specific immunoglobulin E. In spite of the fact that the various therapeutic options have proven their efficacy and effectiveness in a myriad of well-designed clinical trials, many patients express their discontent with current therapies. In several surveys a majority of patients stated that they would prefer nonpharmacological “nonchemical” treatment over what is currently prescribed or recommended by their physicians. This desire stands in clear contrast to a systematic review conducted some years ago proving that there was practically no evidence at that time for the efficacy of alternative forms of treatment of allergic diseases of the upper airways. Ever since, several meta-analyses, systematic reviews, and well-designed clinical trials have been published, bearing witness to the scientific basis of some nonpharmacologic options like nasal irrigation in the treatment of different pathologies of the upper airways, namely, for rhinosinusitis and for allergic rhinoconjunctivitis. In this special issue, we want to highlight some new approaches that until lately have found less public attention in this domain. In their article on the clinical efficacy of a spray containing hyaluronic acid and dexpanthenol after surgery in the nasal cavity, I. Gouteva et al. demonstrate beneficial effects on wound healing for two substances that have a long history of local application in the nose but formerly were used separately. The so-called “extremolyte” ectoine is a substance, which was introduced a few years ago as a “natural” treatment of allergic and inflammatory pathologies of the skin and the mucosal tissues. Five articles in this issue illuminate the mechanism of action and the potential benefits of a nasal spray containing ectoine in diseases of various aetiologies like rhinitis sicca or allergic rhinitis. A form of local treatment of the nasal mucosa that is proximate to ectoine is the nasal spray containing liposomes. Its use in allergic rhinitis has been well established. A. Eitenmuller and coauthors present in their article for the first time data on ectoine in chronic rhinosinusitis. For patients who are sceptical about using any sort of active ingredients in their nasal spray, the application of mere water in the form of thermal water inhalations could be an alternative. S. Keller et al. have conducted a meta-analysis which demonstrates some benefits of this least-invasive local therapy. There has been much controversy over the last decade on the meaningfulness of probiotics in preventing allergies. New forms now come as treatment of chronic diseases of the upper airways. M. F. Kramer and his coauthor M. D. Heath present the latest state of knowledge of this nutritional therapeutic approach. Another much debated therapy in the field of allergic diseases is acupuncture. Most investigations have previously focussed on pollen-allergic patients. It is the merit of Hauswald and coauthors to have conducted a randomized controlled clinical trial using acupuncture as an alternative to treatment with the state-of-the-art antihistamine loratadine in house dust allergic patients. It has been the intention of the editors of this special issue to round up our knowledge on alternative therapies for upper airways diseases beyond the fields of herbal medicine and homeopathy. The number of articles that have been submitted but more so their quality was a positive surprise. We are very grateful to the publishers who have had the courage of disseminating unusual ideas. Ghada Ali and Marie-Josefine Joisten were the driving spirits behind the scenes and without their continuous commitment this special issue would not have seen the light of the day. We are deeply obliged and thankful for their endeavours. Ralph Mosges Carlos E. Baena-Cagnani Desiderio Passali
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prevalence of Skin Sensitization to Pollen of Date Palm in Marrakesh, Morocco. Exploring the Concern about Food Allergies among Secondary School and University Students in Ontario, Canada: A Descriptive Analysis. Validation of the English Version of the Scale for Psychosocial Factors in Food Allergy and the Relationship with Mental Health, Quality of Life, and Self-Efficacy A Simple Allergist-Led Intervention Improves Resident Training in Anaphylaxis Cloning and Expression of Ama r 1, as a Novel Allergen of Amaranthus retroflexus Pollen
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1